Brief: Mimedx Announces Favorable Federal Court Ruling In Axiofill® Regulatory Classification Matter
23/09/2026 22:06
BRIEF-Mimedx Announces Favorable Federal Court Ruling In Axiofill® Regulatory Classification Matter Sept 24 (Reuters) - MiMedx Group, Inc. MDXG.O:
MIMEDX ANNOUNCES FAVORABLE FEDERAL COURT RULING IN AXIOFILL® REGULATORY CLASSIFICATION MATTER
MIMEDX GROUP: COURT VACATES FDA DETERMINATIONS THAT AXIOFILL IS NOT MINIMALLY MANIPULATED AND SHOULD BE CLASSIFIED AS A BIOLOGICAL PRODUCT
MIMEDX GROUP, - COURT CONCLUDES FDA CLASSIFICATION OF AXIOFILL AS BIOLOGICAL PRODUCT WAS "ARBITRARY AND CAPRICIOUS"
Source text: ID:nGNX274yGm
Further company coverage: MDXG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MiMedx
See all newsBrief: Mimedx Announces Favorable Federal Court Ruling In Axiofill® Regulatory Classification Matter
MiMedx Group Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Mimedx To Acquire Sanara Medtech
MiMedx Q2 sales fall less than expected; set to acquire Sanara MedTech
Brief: MiMedx Q2 Sales USD 64.362 Million Vs. IBES Estimate USD 63.5 Million